GlassScriptPhysician profile
Tamara Lee Hansen
NPI 1164101077
$573.46
in general payments reported to CMS, 2019-2025
12 companies · $311 in 2025
The $311 reported for 2025 was more than what 75% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.14 · 2023: $58.37 · 2024: $188 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $159.14 | 2024-2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $69.99 | 2023-2025 | |
| Daiichi Sankyo INC. | $57.92 | 2024-2025 | Injectafer |
| Organon LLC | $54.44 | 2022-2025 | Nexplanon |
| Abbvie INC. | $47.78 | 2024-2025 | |
| Ethicon US, LLC | $43.67 | 2025 | Vistaseal, Dermabond Prineo, Stratafix |
| Bayer Healthcare Pharmaceuticals INC. | $38.44 | 2023-2025 | |
| Hologic Sales and Service, LLC | $34.40 | 2024 | Thinprep 2000 Processor |
| Avanos Medical | $23.49 | 2024 | On-Q* Pump and Accessories |
| Innovation Technologies INC | $15.54 | 2025 | Irrisept |
| C. R. Bard, INC. & Subsidiaries | $14.83 | 2024 | Bd Onclarity |
| Octapharma USA, INC. | $13.82 | 2025 | Fibryga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.